Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

396
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
396
Blind Procedures02:07

Blind Procedures

13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
The Placebo Effect01:54

The Placebo Effect

7.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
7.2K
Blinding01:11

Blinding

4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
Crossover Experiments01:16

Crossover Experiments

4.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.8K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

387
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
387

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sirolimus-Eluting Balloon vs Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis.

Journal of the American College of Cardiology·2026
Same author

Utilization of Model-Informed Drug Development in Early Clinical Development: Case Study of a Hb Modulator for Treatment of Sickle Cell Disease.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Major Adverse Limb Events and Death After Successful Endovascular Revascularization: BEST-CLI Trial.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

A Case Study of AI-Enabled Software as a Medical Device Cleared by the FDA for Assessing Hemorrhage Risk Index (APPRAISE-HRI) after Trauma.

NEJM AI·2026
Same author

Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

High-quality chronic limb-threatening ischemia care requires above average performance in surgical bypass and endovascular treatment.

Journal of vascular surgery·2026

Related Experiment Video

Updated: Apr 15, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.8K

Placebo non-response measure in sequential parallel comparison design studies.

Denis Rybin1, Gheorghe Doros1,2, Michael J Pencina3

  • 1Department of Biostatistics, Boston University, 801 Massachusetts Avenue, Boston, 02118, MA, U.S.A.

Statistics in Medicine
|April 14, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces a weighted repeated measures model for Sequential Parallel Comparison Designs (SPCD) to better analyze placebo response data. The new method improves data utilization and handles subject misclassification, outperforming existing approaches in simulations.

Keywords:
SPCDplacebo effectrepeated measures

More Related Videos

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.4K
Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
08:06

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats

Published on: June 18, 2018

7.8K

Related Experiment Videos

Last Updated: Apr 15, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.8K
Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.4K
Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
08:06

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats

Published on: June 18, 2018

7.8K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacoeconomics

Background:

  • Placebo response is a significant challenge in clinical trials.
  • Sequential Parallel Comparison Designs (SPCD) are novel approaches to address placebo effects.
  • Current SPCD data analysis methods often underutilize collected trial data.

Purpose of the Study:

  • To develop an improved statistical method for analyzing SPCD data.
  • To enhance the utilization of all available data in SPCD trials.
  • To address the issue of potential misclassification of placebo responders and non-responders.

Main Methods:

  • Proposed a weighted repeated measures model for continuous outcomes in SPCD.
  • Incorporated information relevant to placebo response into the analysis.
  • Compared the weighted model against the unweighted repeated measures model via simulations.

Main Results:

  • The weighted repeated measures model demonstrated comparable or superior performance to the unweighted model.
  • The new approach effectively preserved type I error rates.
  • Adequate statistical power was achieved, and mean squared error was minimized.

Conclusions:

  • The weighted repeated measures model offers a more effective way to analyze SPCD data.
  • This method improves data utilization and robustly handles placebo response complexities.
  • The findings suggest a significant advancement in statistical analysis for SPCD trials.